• 1. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 5. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenylpyrazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Phenylpyrazoles

Introduction to 2-(3-phenyl-1H-pyrazol-1-yl)acetic acid (CAS No. 959574-98-2) in Modern Chemical and Pharmaceutical Research

2-(3-phenyl-1H-pyrazol-1-yl)acetic acid, identified by the chemical identifier CAS No. 959574-98-2, represents a significant compound in the realm of medicinal chemistry and bioorganic synthesis. This heterocyclic derivative, featuring a pyrazole core appended to an acetic acid moiety, has garnered considerable attention due to its versatile structural framework and potential pharmacological applications. The pyrazole ring, a nitrogen-containing five-membered aromatic system, is renowned for its broad spectrum of biological activities, while the acetic acid side chain introduces further modularity for functionalization. Such structural attributes make 2-(3-phenyl-1H-pyrazol-1-yl)acetic acid a valuable scaffold for designing novel therapeutic agents.

The compound's molecular structure, characterized by a phenyl group at the 3-position of the pyrazole ring, enhances its interaction with biological targets through π-stacking and hydrophobic effects. This feature has been exploited in various research endeavors, particularly in the development of kinase inhibitors and other enzyme-targeting molecules. Recent advancements in computational chemistry have further illuminated the binding affinity and orientation of 2-(3-phenyl-1H-pyrazol-1-yl)acetic acid with protein receptors, providing insights into its mechanism of action. These studies underscore the compound's potential as a lead molecule in drug discovery campaigns.

In the context of contemporary pharmaceutical research, 2-(3-phenyl-1H-pyrazol-1-yl)acetic acid has been investigated for its role in modulating inflammatory pathways and cancer-related signaling cascades. The pyrazole moiety is particularly noteworthy for its ability to interfere with key enzymes such as Janus kinases (JAKs), which are implicated in autoimmune diseases and certain types of cancer. Preclinical studies have demonstrated that derivatives of this compound exhibit promising anti-inflammatory properties by inhibiting JAK-dependent signaling pathways. This aligns with the growing interest in targeted immunomodulatory therapies that seek to mitigate chronic inflammatory conditions without systemic immunosuppression.

The acetic acid functionality in 2-(3-phenyl-1H-pyrazol-1-yl)acetic acid also serves as a versatile handle for further chemical modifications. Researchers have leveraged this moiety to introduce diverse substituents, thereby tailoring the pharmacokinetic and pharmacodynamic profiles of analogs. For instance, amide or ester derivatives have been explored to enhance solubility and metabolic stability, while alkylation or halogenation strategies have been employed to improve binding affinity. Such synthetic manipulations highlight the compound's adaptability as a building block for medicinal chemistry libraries.

Emerging research also suggests that 2-(3-phenyl-1H-pyrazol-1-yl)acetic acid may find utility in neurodegenerative disease models. The phenyl-pyrazole scaffold exhibits structural similarity to certain natural products known to interact with central nervous system (CNS) receptors. Preliminary investigations have indicated potential neuroprotective effects against oxidative stress-induced neuronal damage, raising hopes for its application in conditions such as Alzheimer's disease or Parkinson's disease. While these findings are still in nascent stages, they underscore the broad therapeutic potential of this class of compounds.

The synthesis of 2-(3-phenyl-1H-pyrazol-1-yl)acetic acid itself presents an interesting challenge due to the need for precise functionalization around the heterocyclic core. Modern synthetic methodologies, including transition-metal-catalyzed cross-coupling reactions and organometallic transformations, have enabled efficient access to this motif. Advances in flow chemistry have further streamlined its production, allowing for scalable synthesis under controlled conditions. These methodological improvements are crucial for facilitating high-throughput screening campaigns and accelerating drug discovery pipelines.

From a computational perspective, virtual screening techniques have been instrumental in identifying novel derivatives of 2-(3-phenyl-1H-pyrazol-1-y]acetic acid) with enhanced biological activity. Machine learning models trained on large datasets of bioactive compounds have predicted optimal substituents that could improve potency or selectivity against desired targets. Such computational approaches complement experimental efforts by providing rational guidance for synthetic design, thereby expediting the optimization process.

The growing body of literature on 2-(3 phenyl - 1 H - pyrazol - 1 - yl ) acetic acid underscores its significance as a pharmacophore in contemporary drug discovery. Its unique structural features—combining a bioactive heterocycle with a functional side chain—make it an attractive candidate for further exploration. As research continues to uncover new therapeutic applications and synthetic strategies, this compound is poised to remain at the forefront of medicinal chemistry innovation.

• 353514-39-3((4-Formyl-3-phenyl-1H-pyrazol-1-yl)acetic acid)
• 959584-25-9(2-(3-(4-Methoxyphenyl)-1H-pyrazol-1-yl)acetic acid)
• 880546-70-3(1H-PYRAZOLE, 1,1'-(OXYDI-2,1-ETHANEDIYL)BIS[3-PHENYL-)
• 113336-27-9(2-(3-phenyl-1H-pyrazol-1-yl)acetamide)
• 1006464-16-9(2-3-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazol-1-ylacetic acid)
• 959573-30-9([3-(4-methylphenyl)-1h-pyrazol-1-yl]acetic Acid)
• 1006329-68-5((3,5-Di-p-tolyl-pyrazol-1-yl)-acetic acid ethyl ester)
• 93323-67-2(Pyrazole-1-acetic Acid, 3,5-diphenyl-)
• 325970-02-3({3-[3-(trifluoromethyl)phenyl]-1h-pyrazol-1-yl}acetic Acid)
• 61308-30-3(1H-Indazole-1-acetic acid, 3-phenyl-)